Form 4: National Health Investors Director Robert A. McCabe Jr. Acquires Shares

Director Robert A. McCabe Jr. of National Health Investors Inc. (NHI) purchased 437 shares of common stock at $65.8312 per share on May 31, 2024.

Summary

• On May 31, 2024, Robert A. McCabe Jr., a director of National Health Investors Inc. (NHI), acquired 437 shares of common stock.
• The purchase price was $65.8312 per share.
• Following the transaction, McCabe directly owns 21,585 shares of NHI common stock.
• McCabe also holds options to purchase 25,000 shares (expiring 02/21/2025), 25,000 shares (expiring 02/25/2026), 25,000 shares (expiring 02/25/2027), 10,000 shares (expiring 02/24/2028), and 10,000 shares (expiring 02/23/2029).

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of a director's stock purchase, which can be seen as a slightly positive signal, but it's not a major event.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

This filing is a routine disclosure of insider trading activity, which is common in publicly traded companies. It provides transparency to investors regarding the actions of company insiders.

Comparison to Industry Standards

• Form 4 filings are standard practice for directors and officers of publicly traded companies, ensuring transparency in their trading activities.
• The size of the purchase (437 shares) is relatively small compared to the total outstanding shares of NHI, but it still provides insight into the director's investment decisions.

Stakeholder Impact

• The stock purchase could have a minor positive impact on shareholder sentiment.

Key Dates